Background
Coronavirus disease 2019 (COVID-19) has been associated with cutaneous
findings, some being the result of drug hypersensitivity reactions such
as maculopapular drug rashes (MDR). The aim of this study was to
investigate whether COVID-19 is associated with the development of the
MDR.